| Name | Title | Contact Details |
|---|
Since its inception in 1970, Microcopy has been at the forefront in the design and development of diamond and carbide burs for the dental industry. Our NeoDiamond product line—America`s #1 selling diamond—is among the most respected in the dental marketplace. Our team of engineers, marketers and production experts design, package and perform complete product inspections following our ISO-certified quality management system. Because we are a full-service solution for our customers, we are able to provide unparalleled support complete with a 100% performance guarantee. Our mission at Microcopy is to provide a strong sense of satisfaction to each customer by offering truly innovative, effective, high-value products. This combined with a courteous and responsive customer service team is what keeps our loyal customers coming back and inspires them to spread the word about our products to their peers.
O2 Concepts has reimagined non-delivery, stepping forward as the first manufacturer to create a smart POC integrated over the Verizon Network that benefits dealers and patients alike. Dynamic Network Analysis (DNA) allows oxygen providers to monitor all devices remotely for location, usage and performance, as well as troubleshoot to prevent any unnecessary dispatches. DNA Technology™ serves as an additional upgrade to 24/7 reliability and the Oxlife Independence`s standard 5 year warranty. O2 Concepts is privately held with factory operations in Newtown, CT and all products are proudly made in the USA.
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.
Rios Nutritional and Med Pdts is a Morton, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Allcare Medical is a Sayreville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.